CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer

Cells Tissues Organs

Volumn 185, Issue 1-3, 2007, Pages 95-99

  Kleer, Celina G ^a,b   Zhang, Yanhong ^a   Merajver, Sofia D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 3510C Medical Sciences Research Building 1 ^*  (United States)

Author keywords

Breast cancer; CCN; CCN6; Epithelial mesenchymal transition; Inflammatory breast cancer; WISP; WISP3

Indexed keywords

CYSTEINE RICH PROTEIN 6; MESSENGER RNA; PROTEIN; SOMATOMEDIN BINDING PROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

BREAST CANCER; CANCER INHIBITION; CELL IMMORTALIZATION; CONFERENCE PAPER; DIMERIZATION; DOWN REGULATION; HUMAN; IN SITU HYBRIDIZATION; MITOSIS INHIBITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STRUCTURE;

AMINO ACID MOTIFS; BREAST NEOPLASMS; CADHERINS; CONSERVED SEQUENCE; EPITHELIAL CELLS; EPITHELIUM; FEMALE; FORECASTING; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MESODERM; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PHENOTYPE; TUMOR SUPPRESSOR PROTEINS;

EID: 34250767642     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101308     Document Type: Conference Paper

References (35)

1. Allen, N.E., A.W. Roddam, D.S. Allen, I.S. Fentiman, I. Dos Santos Silva, J. Peto, J.M. Holly, T.J. Key (2005) A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92: 1283-1287.
2. Benini, S., B. Perbal, D. Zambelli, M.P. Colombo, M.C. Manara, M. Serra, M. Parenza, V. Martinez, P. Picci, K. Scotlandi (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24: 4349-4361.
3. Bleau, A.M., N. Planque, B. Perbal (2005) CCN proteins and cancer: two to tango. Front Biosci 10: 998-1009.
4. Brigstock, D.R., R. Goldschmeding, K.I. Katsube, S.C. Lam, L.F. Lau, K. Lyons, C. Naus, B. Perbal, B. Riser, M. Takigawa, H. Yeger (2003) Proposal for a unified CCN nomenclature. Mol Pathol 56: 127-128.
5. Brigstock, D., L. Lau, B. Perbal (2005) CCN workshop. J Clin Pathol 58: 463-465.
6. Byrne, C., G.A. Colditz, W.C. Willett, F.E. Speizer, M. Pollak, S.E. Hankinson (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60: 3744-3748.
7. Byun, D., S. Mohan, D.J. Baylink, X. Qin (2001) Localization of the IGF binding domain and evaluation of the role of cysteine residues in IGF binding in IGF binding protein-4. J Endocrinol 169: 135-143.
8. Davis, L., Y. Chen, M. Sen (2006) WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem Biophys Res Commun 342: 259-265.
9. Diorio, C., M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, C. Morin, J. Brisson (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14: 1065-1073.
10. Grotendorst, G.R., M.R. Duncan (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19: 729-738.
11. Hurvitz, J.R., W.M. Suwairi, W. Van Hul, H. El-Shanti, A. Superti-Furga, J. Roudier, D. Holderbaum, R.M. Pauli, J.K. Herd, E.V. Van Hul, H. Rezai-Delui, E. Legius, M. Le Merrer, J. Al-Alami, S.A. Bahabri, M.L. Warman (1999) Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 23: 94-98.
12. Imai, Y., A. Moralez, U. Andag, J.B. Clarke, W.H. Busby Jr, D.R. Clemmons (2000) Substitutions for hydrophobic amino acids in the Nterminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275: 18188-18194.
13. Jaiyesimi, I.A., A.U. Buzdar, G. Hortobagyi (1992) Inflammatory breast cancer: a review. J Clin Oncol 10: 1014-1024.
14. Kleer, C.G., K.L. van Golen, T. Braun, S.D. Merajver (2001) Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol 14: 458-464.
15. Kleer, C.G., Y. Zhang, Q. Pan, K.L. van Golen, Z.F. Wu, D. Livant, S.D. Merajver (2002) WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21: 3172-3180.
16. Kleer, C.G., Y. Zhang, Q. Pan, S.D. Merajver (2004) WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 6: 179-185.
17. Kowalski, P.J., M.A. Rubin, C.G. Kleer (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5: R217-R222.
18. Lau, L.F., S.C. Lam (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248: 44-57.
19. Lee, B.J., N.D. Tannenbaum (1924) Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet 39: 580-595.
20. Li, C.L., V. Martinez, B. He, A. Lombet, B. Perbal (2002) A role for CCN3 (NOV) in calcium signalling. Mol Pathol 55: 250-261.
21. Lin, C.G., S.J. Leu, N. Chen, C.M. Tebeau, S.X. Lin, C.Y. Yeung, L.F. Lau (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278: 24200-24208.
22. Lin, C.G., C.C. Chen, S.J. Leu, T.M. Grzeszkiewicz, L.F. Lau (2005) Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem 280: 8229-8237.
23. Manara, M.C., B. Perbal, S. Benini, R. Strammiello, V. Cerisano, S. Perdichizzi, M. Serra, A. Astolfi, F. Bertoni, J. Alami, H. Yeger, P. Picci, K. Scotlandi (2002) The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160: 849-859.
24. Oka, H., H. Shiozaki, K. Kobayashi, M. Inoue, H. Tahara, T. Kobayashi, Y. Takatsuka, N. Matsuyoshi, S. Hirano, M. Takeichi, et al. (1993) Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701.
25. Palacios, J., N. Benito, A. Pizarro, A. Suarez, J. Espada, A. Cano, C. Gamallo (1995) Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 146: 605-612.
26. Pennica, D., T.A. Swanson, J.W. Welsh, M.A. Roy, D.A. Lawrence, J. Lee, J. Brush, L.A. Taneyhill, B. Deuel, M. Lew, C. Watanabe, R.L. Cohen, M.F. Melhem, G.G. Finley, P. Quirke, A.D. Goddard, K.J. Hillan, A.L. Gurney, D. Botstein, A.J. Levine (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95: 14717-14722.
27. Perbal, B. (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54: 57-79.
28. Perbal, B., C. Martinerie, R. Sainson, M. Werner, B. He, B. Roizman (1999a) The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci USA 96: 869-874.
29. Perbal, B., C. Martinerie, R. Sainson, M. Werner, B. He, B. Roizman (1999b) The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci USA 96: 869-874.
30. Rasbridge, S.A., C.E. Gillett, S.A. Sampson, F.S. Walsh, R.R. Millis (1993) Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169: 245-250.
31. Sakamoto, K., S. Yamaguchi, R. Ando, A. Miyawaki, Y. Kabasawa, M. Takagi, C.L. Li, B. Perbal, K. Katsube (2002) The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem 277: 29399-29405.
32. Schernhammer, E.S., J.M. Holly, M.N. Pollak, S.E. Hankinson (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 699-704.
33. van Golen, K.L., S. Davies, Z.F. Wu, Y. Wang, C.D. Bucana, H. Root, S. Chandrasekharappa, M. Strawderman, S.P. Ethier, S.D. Merajver (1999) A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5: 2511-2519.
34. Yang, G.P., L.F. Lau (1991) Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 2: 351-357.
35. Zhang, Y., Q. Pan, H. Zhong, S.D. Merajver, C.G. Kleer (2005) Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res 7: R1080-R1089.